Sahruh Turkmen

Dr. Sahruh Turkmen

clinical science, obstetrics and gynecology, Umeå University, Umeå, Västerbotten, Sweden
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2018 in Journal of Pregnancy
Verified
Journal Article
Open access
PDF file
STSahruh Turkmen
Sahruh Turkmen
SJSimona Johansson
Simona Johansson
MDMarju Dahmoun
Marju Dahmoun
To investigate how macrosomia affects foetal-maternal birth outcomes, we conducted a retrospective cohort study of singleton pregnant women who gave birth at gestational age ≥37+0 weeks. The patients were divided into three groups according to birth weight: “macrosomia” group, ≥4500 g, n=285; “upper-normal” group, 3500–4499 g, n=593; and “normal” group, 2500–3499 g, n=495. Foetal-maternal and delivery outcomes were compared among the three groups after adjustment for confounders. Caesarean section was more frequent in the macrosomia group than in upper-normal and normal groups. The duration of labour (p < 0.05) and postpartum care at the hospital (p < 0.001) were the highest in the macrosomia group. Increased birth weight was associated with higher risks of shoulder dystocia (p < 0.001), increased bleeding volume (p < 0.001), and perineal tear (p < 0.05). The Apgar score at 5 minutes (p < 0.05), arterial cord pH (p < 0.001), and partial pressure of O2 (p < 0.05) were lower, while the arterial cord partial pressure of CO2 was higher (p < 0.001), in the macrosomia group. Macrosomia has potentially serious impacts for neonate and mother as a result of a complicated and occasionally traumatic delivery.

21 May 2020 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
ASAnton Sandström
Anton Sandström
MBMarie Bixo
Marie Bixo
MJMaja Johansson
Maja Johansson
TBTorbjörn Bäckström
Torbjörn Bäckström
STSahruh Turkmen
Sahruh Turkmen
Objective: To assess pain symptoms before and after hysterectomy in women with endometriosis.Design: A population‐based registry study.Setting: Sweden.Population: Women aged 18–45 years who underwent hysterectomy for endometriosis between 2010 and 2015.Methods: Pain symptoms before hysterectomy and 12 months after surgery were collected from the Swedish National Quality Register for Gynaecological Surgery (GynOp). Pain symptoms were also assessed by follow‐up surveys after a median follow‐up period of 63 months.Main outcome measures: Pelvic or lower abdominal pain after hysterectomy.Results: The study included 137 women. The proportion of women experiencing pain of any severity decreased by 28% after hysterectomy (P < 0.001). The proportion of women with severe pain symptoms decreased by 76% after hysterectomy (P < 0.001). The majority of women (84%) were satisfied with the surgical result. Presence of severe pain symptoms after the hysterectomy was associated with less satisfaction (P < 0.001). Pain symptoms after surgery, patient satisfaction and the patient's perceived improvement were not significantly different between women whose ovarian tissue was preserved and women who underwent bilateral oophorectomy.Conclusions: We observed a significant, long‐lasting reduction in pain symptoms after hysterectomy among women with endometriosis. Hysterectomy, with the possibility of ovarian preservation, may be a valuable option for women with endometriosis who suffer from severe pain symptoms.Tweetable Hysterectomy is a valuable option for women with endometriosis and severe pain symptoms.

25 May 2015 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
HHHelena Hedström
Helena Hedström
TBTorbjörn Bäckström
Torbjörn Bäckström
MBMarie Bixo
Marie Bixo
SNSigrid Nyberg
Sigrid Nyberg
MWMingde Wang
Mingde Wang
STSahruh Turkmen
Sahruh Turkmen

1 January 2018 in Frontiers in Neuroendocrinology
Verified
Journal Article
Open access
EHE. Holmberg
E. Holmberg
JSJ. Sjöstedt
J. Sjöstedt
EME. Malinina
E. Malinina
MJM. Johansson
M. Johansson
STSahruh Turkmen
Sahruh Turkmen
TBTORBJÖRN CARL BÄCKSTRÖM
TORBJÖRN CARL BÄCKSTRÖM
Obesity is strongly associated with ill health, primarily caused by consumption of excessive calories, and promoted (inter alia) by gamma-amino-butyric-acid (GABA) stimulating food intake by activating GABAA receptors (primarily with α3 and α2 subunits) in the hypothalamic arcuate nucleus and paraventricular nucleus. Allopregnanolone is a potent positive GABAA receptor modulating steroid (GAMS). As reviewed here, elevated allopregnanolone levels are associated with increases in food intake, preferences for energy-rich food, and obesity in humans and other mammals. In women with polycystic ovarian disease, high serum allopregnanolone concentrations are linked to uncontrolled eating, and perturbed sensitivity to allopregnanolone. Increases in weight during pregnancy also correlate with increases in allopregnanolone levels. Moreover, Prader-Willis syndrome is associated with massive overeating, absence of a GABAA receptor (with compensatory >12-, >5- and >1.5-fold increases in α4, γ2, and α1, α3 subunits), and increases in the α4, βx, δ receptor subtype, which is highly sensitive to allopregnanolone. GABA and positive GABA-A receptor modulating steroids like allopregnanolone stimulates food intake and weight gain.

29 July 2018 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
PDF file
STSahruh Turkmen
Sahruh Turkmen
MTMaja Tjernström
Maja Tjernström
MDMarju Dahmoun
Marju Dahmoun
MBMarie Bolin
Marie Bolin

16 May 2015 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
STSahruh Turkmen
Sahruh Turkmen
AAAlebtekin Ahangari
Alebtekin Ahangari
TBTorbjörn Bäckstrom
Torbjörn Bäckstrom